Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
Entry of exogenous polypeptides into the nucleus of living cells: facts and speculations.

Trends in cell biology

Rubartelli A, Sitia R.
PMID: 14732039
Trends Cell Biol. 1995 Nov;5(11):409-12. doi: 10.1016/s0962-8924(00)89093-5.

Although the plasma membrane acts as an impermeable barrier to most macromolecules, some exogenous proteins (for example fibroblast growth factor, HIV-1 Tat and lactoferrin) can gain access into the cytosol and reach the nucleus of living cells. How are...

Cite
Rubartelli A, Sitia R. Entry of exogenous polypeptides into the nucleus of living cells: facts and speculations. Trends Cell Biol. 1995;5(11):409-12doi: 10.1016/s0962-8924(00)89093-5.
Rubartelli, A., & Sitia, R. (1995). Entry of exogenous polypeptides into the nucleus of living cells: facts and speculations. Trends in cell biology, 5(11), 409-12. https://doi.org/10.1016/s0962-8924(00)89093-5
Rubartelli, A, and Sitia, R. "Entry of exogenous polypeptides into the nucleus of living cells: facts and speculations." Trends in cell biology vol. 5,11 (1995): 409-12. doi: https://doi.org/10.1016/s0962-8924(00)89093-5
Rubartelli A, Sitia R. Entry of exogenous polypeptides into the nucleus of living cells: facts and speculations. Trends Cell Biol. 1995 Nov;5(11):409-12. doi: 10.1016/s0962-8924(00)89093-5. PMID: 14732039.
Copy Download .nbib Format: NLM
A novel way to get out of the cell.

Cytotechnology

Rubartelli A, Bajetto A, Bonifaci N, Di Blas E, Solito E, Sitia R.
PMID: 22358704
Cytotechnology. 1993 Jan;11:S37-40. doi: 10.1007/BF00746049.

No abstract available.

Cite
Rubartelli A, Bajetto A, Bonifaci N, et al. A novel way to get out of the cell. Cytotechnology. 1993;11:S37-40doi: 10.1007/BF00746049.
Rubartelli, A., Bajetto, A., Bonifaci, N., Di Blas, E., Solito, E., & Sitia, R. (1993). A novel way to get out of the cell. Cytotechnology, 11S37-40. https://doi.org/10.1007/BF00746049
Rubartelli, A, et al. "A novel way to get out of the cell." Cytotechnology vol. 11 (1993): S37-40. doi: https://doi.org/10.1007/BF00746049
Rubartelli A, Bajetto A, Bonifaci N, Di Blas E, Solito E, Sitia R. A novel way to get out of the cell. Cytotechnology. 1993 Jan;11:S37-40. doi: 10.1007/BF00746049. PMID: 22358704.
Copy Download .nbib Format: NLM
Increased myocardial .

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Bauckneht M, Pastorino F, Castellani P, Cossu V, Orengo AM, Piccioli P, Emionite L, Capitanio S, Yosifov N, Bruno S, Lazzarini E, Ponzoni M, Ameri P, Rubartelli A, Ravera S, Morbelli S, Sambuceti G, Marini C.
PMID: 30737636
J Nucl Cardiol. 2020 Dec;27(6):2183-2194. doi: 10.1007/s12350-019-01618-x. Epub 2019 Feb 08.

BACKGROUND: Oxidative stress and its interference on myocardial metabolism play a major role in Doxorubicin (DXR) cardiotoxic cascade.METHODS: Mice models of neuroblastoma (NB) were treated with 5 mg DXR/kg, either free (Free-DXR) or encapsulated in untargeted (SL[DXR]) or in...

Cite
Bauckneht M, Pastorino F, Castellani P, et al. Increased myocardial . J Nucl Cardiol. 2019;27(6):2183-2194doi: 10.1007/s12350-019-01618-x.
Bauckneht, M., Pastorino, F., Castellani, P., Cossu, V., Orengo, A. M., Piccioli, P., Emionite, L., Capitanio, S., Yosifov, N., Bruno, S., Lazzarini, E., Ponzoni, M., Ameri, P., Rubartelli, A., Ravera, S., Morbelli, S., Sambuceti, G., & Marini, C. (2020). Increased myocardial . Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 27(6), 2183-2194. https://doi.org/10.1007/s12350-019-01618-x
Bauckneht, Matteo, et al. "Increased myocardial ." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. 27,6 (2020): 2183-2194. doi: https://doi.org/10.1007/s12350-019-01618-x
Bauckneht M, Pastorino F, Castellani P, Cossu V, Orengo AM, Piccioli P, Emionite L, Capitanio S, Yosifov N, Bruno S, Lazzarini E, Ponzoni M, Ameri P, Rubartelli A, Ravera S, Morbelli S, Sambuceti G, Marini C. Increased myocardial . J Nucl Cardiol. 2020 Dec;27(6):2183-2194. doi: 10.1007/s12350-019-01618-x. Epub 2019 Feb 08. PMID: 30737636.
Copy Download .nbib Format: NLM
Insulin action in subjects with type 2 diabetes following biliopancreatic diversion.

European journal of clinical investigation

Papadia F, Carlini F, Rubartelli A, Battistini M, Cordera R, Adami GF, Camerini G.
PMID: 34902158
Eur J Clin Invest. 2021 Dec 12;e13727. doi: 10.1111/eci.13727. Epub 2021 Dec 12.

No abstract available.

Cite
Papadia F, Carlini F, Rubartelli A, et al. Insulin action in subjects with type 2 diabetes following biliopancreatic diversion. Eur J Clin Invest. 2021;e13727doi: 10.1111/eci.13727.
Papadia, F., Carlini, F., Rubartelli, A., Battistini, M., Cordera, R., Adami, G. F., & Camerini, G. (2021). Insulin action in subjects with type 2 diabetes following biliopancreatic diversion. European journal of clinical investigation, e13727. https://doi.org/10.1111/eci.13727
Papadia, Francesco, et al. "Insulin action in subjects with type 2 diabetes following biliopancreatic diversion." European journal of clinical investigation vol. (2021): e13727. doi: https://doi.org/10.1111/eci.13727
Papadia F, Carlini F, Rubartelli A, Battistini M, Cordera R, Adami GF, Camerini G. Insulin action in subjects with type 2 diabetes following biliopancreatic diversion. Eur J Clin Invest. 2021 Dec 12;e13727. doi: 10.1111/eci.13727. Epub 2021 Dec 12. PMID: 34902158.
Copy Download .nbib Format: NLM
Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models.

Cancer medicine

Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P.
PMID: 34796694
Cancer Med. 2022 Jan;11(1):183-193. doi: 10.1002/cam4.4371. Epub 2021 Nov 18.

Triple negative breast cancers (TNBCs) are very aggressive and have a poor prognosis due to lack of efficacious therapies. The only effective treatment is chemotherapy that however is frequently hindered by the occurrence of drug resistance. We approached this...

Cite
Balza E, Carlone S, Carta S, et al. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2021;11(1):183-193doi: 10.1002/cam4.4371.
Balza, E., Carlone, S., Carta, S., Piccioli, P., Cossu, V., Marini, C., Sambuceti, G., Rubartelli, A., & Castellani, P. (2022). Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer medicine, 11(1), 183-193. https://doi.org/10.1002/cam4.4371
Balza, Enrica, et al. "Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models." Cancer medicine vol. 11,1 (2022): 183-193. doi: https://doi.org/10.1002/cam4.4371
Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2022 Jan;11(1):183-193. doi: 10.1002/cam4.4371. Epub 2021 Nov 18. PMID: 34796694.
Copy Download .nbib Format: NLM
Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models.

Cancer medicine

Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P.
PMID: 34796694
Cancer Med. 2022 Jan;11(1):183-193. doi: 10.1002/cam4.4371. Epub 2021 Nov 18.

Triple negative breast cancers (TNBCs) are very aggressive and have a poor prognosis due to lack of efficacious therapies. The only effective treatment is chemotherapy that however is frequently hindered by the occurrence of drug resistance. We approached this...

Cite
Balza E, Carlone S, Carta S, et al. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2021;11(1):183-193doi: 10.1002/cam4.4371.
Balza, E., Carlone, S., Carta, S., Piccioli, P., Cossu, V., Marini, C., Sambuceti, G., Rubartelli, A., & Castellani, P. (2022). Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer medicine, 11(1), 183-193. https://doi.org/10.1002/cam4.4371
Balza, Enrica, et al. "Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models." Cancer medicine vol. 11,1 (2022): 183-193. doi: https://doi.org/10.1002/cam4.4371
Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2022 Jan;11(1):183-193. doi: 10.1002/cam4.4371. Epub 2021 Nov 18. PMID: 34796694; PMCID: PMC8704177.
Copy Download .nbib Format: NLM
DAMP-Mediated Activation of NLRP3-Inflammasome in Brain Sterile Inflammation: The Fine Line between Healing and Neurodegeneration.

Frontiers in immunology

Rubartelli A.
PMID: 24672523
Front Immunol. 2014 Mar 17;5:99. doi: 10.3389/fimmu.2014.00099. eCollection 2014.

No abstract available.

Cite
Rubartelli A. DAMP-Mediated Activation of NLRP3-Inflammasome in Brain Sterile Inflammation: The Fine Line between Healing and Neurodegeneration. Front Immunol. 2014;5:99doi: 10.3389/fimmu.2014.00099.
Rubartelli, A. (2014). DAMP-Mediated Activation of NLRP3-Inflammasome in Brain Sterile Inflammation: The Fine Line between Healing and Neurodegeneration. Frontiers in immunology, 599. https://doi.org/10.3389/fimmu.2014.00099
Rubartelli, Anna. "DAMP-Mediated Activation of NLRP3-Inflammasome in Brain Sterile Inflammation: The Fine Line between Healing and Neurodegeneration." Frontiers in immunology vol. 5 (2014): 99. doi: https://doi.org/10.3389/fimmu.2014.00099
Rubartelli A. DAMP-Mediated Activation of NLRP3-Inflammasome in Brain Sterile Inflammation: The Fine Line between Healing and Neurodegeneration. Front Immunol. 2014 Mar 17;5:99. doi: 10.3389/fimmu.2014.00099. eCollection 2014. PMID: 24672523; PMCID: PMC3956122.
Copy Download .nbib Format: NLM
The Role of Emotional Competences in Parents' Vaccine Hesitancy.

Vaccines

Gavaruzzi T, Caserotti M, Leo I, Tasso A, Speri L, Ferro A, Fretti E, Sannino A, Rubaltelli E, Lotto L.
PMID: 33810071
Vaccines (Basel). 2021 Mar 22;9(3). doi: 10.3390/vaccines9030298.

The role of parents' emotional competencies on vaccine hesitancy and decision making has been seldom examined. Two studies investigated the relationship between parents' attitudes towards childhood vaccines and self-reported behavior (Study 1) and between parents' emotional competence and attitudes...

Cite
Gavaruzzi T, Caserotti M, Leo I, et al. The Role of Emotional Competences in Parents' Vaccine Hesitancy. Vaccines (Basel). 2021;9(3)doi: 10.3390/vaccines9030298.
Gavaruzzi, T., Caserotti, M., Leo, I., Tasso, A., Speri, L., Ferro, A., Fretti, E., Sannino, A., Rubaltelli, E., & Lotto, L. (2021). The Role of Emotional Competences in Parents' Vaccine Hesitancy. Vaccines, 9(3), . https://doi.org/10.3390/vaccines9030298
Gavaruzzi, Teresa, et al. "The Role of Emotional Competences in Parents' Vaccine Hesitancy." Vaccines vol. 9,3 (2021). doi: https://doi.org/10.3390/vaccines9030298
Gavaruzzi T, Caserotti M, Leo I, Tasso A, Speri L, Ferro A, Fretti E, Sannino A, Rubaltelli E, Lotto L. The Role of Emotional Competences in Parents' Vaccine Hesitancy. Vaccines (Basel). 2021 Mar 22;9(3). doi: 10.3390/vaccines9030298. PMID: 33810071; PMCID: PMC8005154.
Copy Download .nbib Format: NLM
Shockwave intravascular lithotripsy in the treatment of under-expanded coronary stent: Case Series.

Clinical case reports

Fedele M, Iannone A, Bartolini D, Rubartelli P.
PMID: 34707865
Clin Case Rep. 2021 Oct 19;9(10):e04961. doi: 10.1002/ccr3.4961. eCollection 2021 Oct.

Under-expanded coronary stent related to inadequate preparation of calcified lesion is associated with poor clinical outcomes.Off-label use of S-IVL to correct this clinical issue is effective and safe, probably more than other current techniques. However, this statement needs further...

Cite
Fedele M, Iannone A, Bartolini D, et al. Shockwave intravascular lithotripsy in the treatment of under-expanded coronary stent: Case Series. Clin Case Rep. 2021;9(10):e04961doi: 10.1002/ccr3.4961.
Fedele, M., Iannone, A., Bartolini, D., & Rubartelli, P. (2021). Shockwave intravascular lithotripsy in the treatment of under-expanded coronary stent: Case Series. Clinical case reports, 9(10), e04961. https://doi.org/10.1002/ccr3.4961
Fedele, Massimiliano, et al. "Shockwave intravascular lithotripsy in the treatment of under-expanded coronary stent: Case Series." Clinical case reports vol. 9,10 (2021): e04961. doi: https://doi.org/10.1002/ccr3.4961
Fedele M, Iannone A, Bartolini D, Rubartelli P. Shockwave intravascular lithotripsy in the treatment of under-expanded coronary stent: Case Series. Clin Case Rep. 2021 Oct 19;9(10):e04961. doi: 10.1002/ccr3.4961. eCollection 2021 Oct. PMID: 34707865; PMCID: PMC8527023.
Copy Download .nbib Format: NLM
Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models.

Cancer medicine

Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P.
PMID: 34796694
Cancer Med. 2021 Nov 18; doi: 10.1002/cam4.4371. Epub 2021 Nov 18.

Triple negative breast cancers (TNBCs) are very aggressive and have a poor prognosis due to lack of efficacious therapies. The only effective treatment is chemotherapy that however is frequently hindered by the occurrence of drug resistance. We approached this...

Cite
Balza E, Carlone S, Carta S, et al. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2021;doi: 10.1002/cam4.4371.
Balza, E., Carlone, S., Carta, S., Piccioli, P., Cossu, V., Marini, C., Sambuceti, G., Rubartelli, A., & Castellani, P. (2021). Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer medicine, . https://doi.org/10.1002/cam4.4371
Balza, Enrica, et al. "Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models." Cancer medicine vol. (2021). doi: https://doi.org/10.1002/cam4.4371
Balza E, Carlone S, Carta S, Piccioli P, Cossu V, Marini C, Sambuceti G, Rubartelli A, Castellani P. Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models. Cancer Med. 2021 Nov 18; doi: 10.1002/cam4.4371. Epub 2021 Nov 18. PMID: 34796694.
Copy Download .nbib Format: NLM
Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes.

Obesity surgery

Papadia FS, Carlini F, Rubartelli A, Battistini M, Cordera R, Adami GF, Camerini G.
PMID: 35013895
Obes Surg. 2022 Jan 10; doi: 10.1007/s11695-021-05870-4. Epub 2022 Jan 10.

BACKGROUND: Long-term anti-diabetic effects of BPD in overweight or class 1 obese T2DM patients were investigated reporting the results at 10 years after BPD performed in severely non-obese T2DM patients.MATERIAL AND METHODS: Thirty T2DM patients with BMI lower than...

Cite
Papadia FS, Carlini F, Rubartelli A, et al. Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes. Obes Surg. 2022;doi: 10.1007/s11695-021-05870-4.
Papadia, F. S., Carlini, F., Rubartelli, A., Battistini, M., Cordera, R., Adami, G. F., & Camerini, G. (2022). Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes. Obesity surgery, . https://doi.org/10.1007/s11695-021-05870-4
Papadia, Francesco Saverio, et al. "Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes." Obesity surgery vol. (2022). doi: https://doi.org/10.1007/s11695-021-05870-4
Papadia FS, Carlini F, Rubartelli A, Battistini M, Cordera R, Adami GF, Camerini G. Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes. Obes Surg. 2022 Jan 10; doi: 10.1007/s11695-021-05870-4. Epub 2022 Jan 10. PMID: 35013895.
Copy Download .nbib Format: NLM
Integrating an Electronic Health Record System into a Regional Health Information System: An HL7 FHIR Architecture.

Studies in health technology and informatics

Lazarova E, Mora S, Rubartelli P, Cosolito Vitale A, Pareto L, Maggi N, Ruggiero C, Giacomini M.
PMID: 34042850
Stud Health Technol Inform. 2021 May 27;281:1087-1088. doi: 10.3233/SHTI210357.

This paper presents an architecture which has been developed in order to integrate a routinely used cardiologic EHR system into the health information infrastructure system of the region where the EHR is used. A Service Oriented Approach based on...

Cite
Lazarova E, Mora S, Rubartelli P, et al. Integrating an Electronic Health Record System into a Regional Health Information System: An HL7 FHIR Architecture. Stud Health Technol Inform. 2021;281:1087-1088doi: 10.3233/SHTI210357.
Lazarova, E., Mora, S., Rubartelli, P., Cosolito Vitale, A., Pareto, L., Maggi, N., Ruggiero, C., & Giacomini, M. (2021). Integrating an Electronic Health Record System into a Regional Health Information System: An HL7 FHIR Architecture. Studies in health technology and informatics, 2811087-1088. https://doi.org/10.3233/SHTI210357
Lazarova, Elena, et al. "Integrating an Electronic Health Record System into a Regional Health Information System: An HL7 FHIR Architecture." Studies in health technology and informatics vol. 281 (2021): 1087-1088. doi: https://doi.org/10.3233/SHTI210357
Lazarova E, Mora S, Rubartelli P, Cosolito Vitale A, Pareto L, Maggi N, Ruggiero C, Giacomini M. Integrating an Electronic Health Record System into a Regional Health Information System: An HL7 FHIR Architecture. Stud Health Technol Inform. 2021 May 27;281:1087-1088. doi: 10.3233/SHTI210357. PMID: 34042850.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries